Weil, Gotshal & Manges LLP‘s ’responsive and dedicated’ life sciences practice melds an active transactional life practice with a patent practice that covers both patent strategy and disputes before the PTAB and Federal Circuit Courts, working together to see through collaborations and licensing agreements in the sector. The firm’s efforts are spearheaded by patent litigators Elizabeth Weiswasser and Silicon Valley’s Edward Reines, who handle matters pertaining to biologics and small molecules among a range of other complex patent issues. Derek Walter, also based in Silicon Valley, is another name to note for patent litigation in the pharmaceuticals and biotech spaces. Transactions with a substantial IP element are overseen by Jeffrey Osterman and Charan Sandhu, who also advise on joint ventures and technology transfers. Lawyers mentioned are based in New York unless otherwise specified.
Testimonials
Collated independently by Legal 500 research team.
- 'Creative and innovative in their approach. Know the company well and understand our products and technology. Responsive and dedicated.'
Key clients
- CareDx
- Invitae
- Regeneron
- Synthego
- NanoString
- Sanofi
- BeiGene
- Daiichi Sankyo
- Elanco Animal Health
- Johnson & Johnson
- Torrent Pharmaceuticals
- Abbott Laboratories
- Bausch + Lomb
- Eli Lilly
- Quest Diagnostics
Work highlights
- Secured an important decision from the PTAB in favor of Regeneron, protecting the client’s novel biologic to treat macular degeneration and other serious eye diseases.
- Secured the invalidation of two Agilent patents before the PTAB that were asserted against Synthego, a CRISPR-focused synthetic biology company.
- Represented Invitae in bringing two parallel infringement suits against Natera relating to DNA sequencing technology.
Lawyers
Practice head
The lawyer(s) leading their teams.
Elizabeth Weiswasser, Edward Reines